Global Information
회사소개 | 문의 | 비교리스트

칼시필락시스 치료 시장 : 규모, 점유율, 동향, 예측(-2026년)

Calciphylaxis Treatment Market - Size, Share, Trends, and Forecast to 2026

리서치사 Coherent Market Insights
발행일 2018년 10월 상품 코드 754962
페이지 정보 영문
가격
US $ 4,500 ₩ 5,456,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,488,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,126,000 PPT Turned PDF (Enterprise User License)


칼시필락시스 치료 시장 : 규모, 점유율, 동향, 예측(-2026년) Calciphylaxis Treatment Market - Size, Share, Trends, and Forecast to 2026
발행일 : 2018년 10월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

칼시필락시스는 주로 말기 신부전에 의해 투석을 받고 있는 환자에게 발병하며, 난치성 피부 궤양이 주증상인 치사성 높은 질환입니다. 이 질환의 병원은 밝혀져 있지 않으나, 많은 환자가 혈액 응고인자에 이상을 보이는 것으로 알려져 있습니다.

세계의 칼시필락시스 치료(Calciphylaxis Treatment) 시장을 조사했으며, 시장 및 질환의 개요, 치료법·최종사용자·지역별 시장 동향, 시장 성장요인 및 저해요인 분석, 시장 기회, 주요 기업 개요 등에 대해 정리하여 전해드립니다.

목차

제1장 조사 목적과 전제조건

  • 조사
  • 전제조건
  • 약어

제2장 시장 개요

  • 리포트 개요
    • 시장의 정의와 범위
  • 개요
    • 시장 스니펫 : 치료법별
    • 시장 스니펫 : 최종사용자별
    • 시장 스니펫 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장요인
    • 저해요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 주요 개발
  • 임상시험
  • 역학
  • Porter의 산업 분석

제4장 세계의 칼시필락시스 시장 : 치료법별

  • 서론
  • 투약
  • 고압산소요법
  • 수술

제5장 세계의 칼시필락시스 시장 : 최종사용자별

  • 서론
  • 병원·진료소
  • 홈케어
  • 외래 센터

제6장 세계의 칼시필락시스 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 아프리카
  • 중동

제7장 경쟁 구도

  • 히트맵 분석
  • 기업 개요
    • 3M
    • Amgen Inc.
    • BSN Medical
    • ConvaTec Inc.
    • Medtronic Plc.
    • Smith & Nephew Plc.
    • Laboratoris Sanifit S.L.
  • 애널리스트의 견해

제8장 섹션

KSA 18.12.18

Calciphylaxis or calcific uremic arteriolopathy is a syndrome of vascular calcification, thrombosis, and skin necrosis. It mostly occurs in patients with end-stage kidney disease or kidney transplant. Calciphylaxis results in chronic non-healing wounds and is usually fatal. It has a high mortality rate, owing to cardiovascular disease and sepsis caused due to infected skin ulcers. The exact pathogenetic mechanisms of the disease is not known. Most patients with the condition have abnormalities in blood-clotting factors. Multiple interventions are used to treat calciphylaxis, including restoring oxygen and blood flow to the skin, decreasing calcium deposits, and intensive wound treatment.

Market Dynamics

High prevalence of kidney diseases and increasing number of clinical trials in the field of calciphylaxis treatment are major factors expected to drive growth of the calciphylaxis treatment market. According to the National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, in 2016, the overall prevalence of chronic kidney diseases in the U.S. was around 14% of total population.

Calciphylaxis has no approved treatment, which has led to increasing number of clinical trials and research, which is expected to fuel growth of the market. For instance, in March 2015, the Multidisciplinary Calciphylaxis Program launched the first randomized trial for treatment of calciphylaxis with research focus on the role of vitamin K in the treatment of the disease.

Lack of an appropriate treatment for calciphylaxis is a major obstacle in the calciphylaxis treatment market growth. However, key players in the market are focused on identifying the root cause of the disease and its associated treatment in order to gain market share. For instance, according to a study published by the American Journal of Nephrology, in June 2018, apixaban, an anticoagulant used to treat venous thromboembolic events, can be a safe and effective alternative to warfarin in patients with End-Stage Renal Disease (ESRD) on dialysis suffering from calciphylaxis.

Key features of the study:

  • This report provides in-depth analysis of the global calciphylaxis treatment market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global calciphylaxis treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, 3M, Amgen Inc., BSN Medical, ConvaTec Inc., Medtronic Plc., Smith & Nephew Plc., and Laboratoris Sanifit S.L.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global calciphylaxis treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for calciphylaxis treatment market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Calciphylaxis Treatment Market, By Treatment:
    • Drug Therapy
    • Hyperbaric Oxygen Therapy
  • Global Calciphylaxis Treatment Market, By End User:
    • Hospital and Clinics
    • Homecare
    • Ambulatory Centers
  • Global Calciphylaxis Treatment Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Treatment:
    • Drug Therapy
    • Hyperbaric Oxygen Therapy
      • By End User:
    • Hospital and Clinics
    • Homecare
    • Ambulatory Centers
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Treatment:
    • Drug Therapy
    • Hyperbaric Oxygen Therapy
      • By End User:
    • Hospital and Clinics
    • Homecare
    • Ambulatory Centers
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Treatment:
    • Drug Therapy
    • Hyperbaric Oxygen Therapy
      • By End User:
    • Hospital and Clinics
    • Homecare
    • Ambulatory Centers
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Treatment:
    • Drug Therapy
    • Hyperbaric Oxygen Therapy
      • By End User:
    • Hospital and Clinics
    • Homecare
    • Ambulatory Centers
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Treatment:
    • Drug Therapy
    • Hyperbaric Oxygen Therapy
      • By End User:
    • Hospital and Clinics
    • Homecare
    • Ambulatory Centers
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • By Treatment:
    • Drug Therapy
    • Hyperbaric Oxygen Therapy
      • By End User:
    • Hospital and Clinics
    • Homecare
    • Ambulatory Centers
  • Company Profiles
    • 3M*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Amgen Inc.
    • BSN Medical
    • ConvaTec Inc.
    • Medtronic Plc.
    • Smith & Nephew Plc.
    • Laboratoris Sanifit S.L.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Treatment
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Clinical Trials
  • Epidemiology
  • PORTER'S Five Forces

4. Global Calciphylaxis Treatment Market, By Treatment, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Drug Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Hyperbaric Oxygen Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Calciphylaxis Treatment Market, By End User, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Homecare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Ambulatory Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Calciphylaxis Treatment Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • 3M
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Amgen Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BSN Medical
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • ConvaTec Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Medtronic Plc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Smith & Nephew Plc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Laboratoris Sanifit S.L.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top
전화 문의
F A Q